PortfoliosLab logoPortfoliosLab logo
INTC vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

INTC vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Intel Corporation (INTC) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, INTC achieves a 198.83% return, which is significantly higher than NVO's -16.56% return. Over the past 10 years, INTC has outperformed NVO with an annualized return of 15.65%, while NVO has yielded a comparatively lower 6.20% annualized return.


INTC

1D
11.19%
1M
-11.73%
YTD
198.83%
6M
173.62%
1Y
449.70%
3Y*
53.12%
5Y*
16.15%
10Y*
15.65%

NVO

1D
-4.52%
1M
-10.96%
YTD
-16.56%
6M
-9.23%
1Y
-42.47%
3Y*
-17.53%
5Y*
1.78%
10Y*
6.20%
*Multi-year figures are annualized to reflect compound growth (CAGR)

INTC vs. NVO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
INTC
Intel Corporation
198.83%84.04%-59.57%94.56%-46.64%6.05%-14.69%30.71%4.23%30.87%
NVO
Novo Nordisk A/S
-16.56%-39.22%-15.93%54.84%22.66%63.52%23.33%28.70%-12.98%52.92%

Correlation

The correlation between INTC and NVO is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (10Y)
Calculated over the trailing 10-year period

0.20

Correlation (All Time)
Calculated using the full available price history since Jan 5, 1982

0.19

Fundamentals

Market Cap

INTC:

$560.50B

NVO:

$182.49B

EPS

INTC:

-$0.67

NVO:

$27.42

PS Ratio

INTC:

9.66

NVO:

0.56

PB Ratio

INTC:

5.03

NVO:

0.90

Total Revenue (TTM)

INTC:

$53.76B

NVO:

$327.80B

Gross Profit (TTM)

INTC:

$19.05B

NVO:

$268.30B

EBITDA (TTM)

INTC:

$8.83B

NVO:

$181.54B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

INTC vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INTC
INTC Risk / Return Rank: 9898
Overall Rank
INTC Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
INTC Sortino Ratio Rank: 9898
Sortino Ratio Rank
INTC Omega Ratio Rank: 9797
Omega Ratio Rank
INTC Calmar Ratio Rank: 9999
Calmar Ratio Rank
INTC Martin Ratio Rank: 9999
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 1212
Overall Rank
NVO Sharpe Ratio Rank: 99
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 1212
Sortino Ratio Rank
NVO Omega Ratio Rank: 1010
Omega Ratio Rank
NVO Calmar Ratio Rank: 1313
Calmar Ratio Rank
NVO Martin Ratio Rank: 1717
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INTC vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Intel Corporation (INTC) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


INTCNVODifference
Sharpe ratioReturn per unit of total volatility

+6.98

Sortino ratioReturn per unit of downside risk

+6.03

Omega ratioGain probability vs. loss probability

1.64

0.86

+0.78

Calmar ratioReturn relative to maximum drawdown

18.76

-0.77

+19.53

Martin ratioReturn relative to average drawdown

44.28

-1.14

+45.43

INTC vs. NVO - Sharpe Ratio Comparison

The current INTC Sharpe Ratio is 6.16, which is higher than the NVO Sharpe Ratio of -0.82. The chart below compares the historical Sharpe Ratios of INTC and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


INTCNVODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

6.16

-0.82

+6.98

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.31

0.05

+0.27

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.36

0.19

+0.17

Sharpe Ratio (All Time)

Calculated using the full available price history

0.36

0.47

-0.11

Drawdowns

INTC vs. NVO - Drawdown Comparison

The maximum INTC drawdown since its inception was -82.25%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for INTC and NVO.


Loading charts...

Drawdown Indicators


INTCNVODifference

Max Drawdown

Largest peak-to-trough decline

-82.25%

-74.70%

-7.55%

Max Drawdown (1Y)

Largest decline over 1 year

-24.17%

-55.03%

+30.86%

Max Drawdown (3Y)

Largest decline over 3 years

-63.80%

-74.70%

+10.90%

Max Drawdown (5Y)

Largest decline over 5 years

-65.95%

-74.70%

+8.75%

Max Drawdown (10Y)

Largest decline over 10 years

-70.80%

-74.70%

+3.90%

Current Drawdown

Current decline from peak

-14.81%

-70.19%

+55.38%

Average Drawdown

Average peak-to-trough decline

-36.67%

-17.77%

-18.90%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.22%

37.21%

-26.99%

Volatility

INTC vs. NVO - Volatility Comparison

Intel Corporation (INTC) has a higher volatility of 26.82% compared to Novo Nordisk A/S (NVO) at 9.75%. This indicates that INTC's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


INTCNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

26.82%

9.75%

+17.07%

Volatility (6M)

Calculated over the trailing 6-month period

57.68%

38.30%

+19.38%

Volatility (1Y)

Calculated over the trailing 1-year period

73.75%

52.08%

+21.67%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

52.06%

38.31%

+13.75%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

44.07%

32.56%

+11.51%

Dividends

INTC vs. NVO - Dividend Comparison

INTC has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.39%.


PositionTTM20252024202320222021202020192018201720162015
INTC
Intel Corporation
0.00%0.00%1.87%1.47%5.52%2.70%2.65%2.11%2.56%2.33%2.87%2.79%
NVO
Novo Nordisk A/S
4.39%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%

Financials

INTC vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Intel Corporation and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00B40.00B60.00B80.00B100.00B20222023202420252026
13.58B
96.82B
(INTC) Total Revenue
(NVO) Total Revenue
Values in USD except per share items

INTC vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between Intel Corporation and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%20222023202420252026
39.4%
86.0%
Portfolio components
INTC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Intel Corporation reported a gross profit of 5.35B and revenue of 13.58B. Therefore, the gross margin over that period was 39.4%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

INTC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Intel Corporation reported an operating income of -3.14B and revenue of 13.58B, resulting in an operating margin of -23.1%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

INTC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Intel Corporation reported a net income of -3.73B and revenue of 13.58B, resulting in a net margin of -27.5%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.


Frequently Asked Questions


INTC and NVO have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

INTC has higher volatility (26.82%) compared to NVO (9.75%). In terms of maximum drawdown, INTC dropped -82.25% vs NVO's -74.70%.

INTC currently has the higher Sharpe Ratio (6.16 vs -0.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for INTC and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer